Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases

J Control Release. 2006 Nov 28;116(2):e55-6. doi: 10.1016/j.jconrel.2006.09.047.

Authors

Y Tang¹, R R Taylor, M V Gonzalez, A L Lewis, P W Stratford

Affiliation

¹ Biocompatibles UK Ltd, Farnham, Surrey, United Kingdom. yiqing.tang@biocompatibles.com <yiqing.tang@biocompatibles.com>

PMID: 17718969
DOI: 10.1016/j.jconrel.2006.09.047

No abstract available

MeSH terms

Animals
Antineoplastic Agents, Phytogenic / administration & dosage*
Antineoplastic Agents, Phytogenic / blood
Antineoplastic Agents, Phytogenic / chemistry
Antineoplastic Agents, Phytogenic / pharmacokinetics
Camptothecin / administration & dosage
Camptothecin / analogs & derivatives*
Camptothecin / blood
Camptothecin / chemistry
Camptothecin / pharmacokinetics
Chemoembolization, Therapeutic / methods*
Drug Delivery Systems / methods*
Hepatic Artery
Infusions, Intra-Arterial
Irinotecan
Liver Neoplasms / drug therapy
Liver Neoplasms / metabolism
Liver Neoplasms / secondary
Swine

Substances

Antineoplastic Agents, Phytogenic
Irinotecan
Camptothecin